{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:47:03Z","timestamp":1792698423480,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE 2241144"],"award-info":[{"award-number":["DGE 2241144"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R00EB028840"],"award-info":[{"award-number":["R00EB028840"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE007057-43"],"award-info":[{"award-number":["DE007057-43"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jconrel.2025.114564","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T23:17:35Z","timestamp":1766272655000},"page":"114564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Antigen-conjugated scaffolds enable sustained delivery of antigen and enrichment of antigen-specific T-cells"],"prefix":"10.1016","volume":"390","author":[{"given":"Sydney N.","family":"Wheeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Dickenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor N.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha N.","family":"Lukpat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J.M.W.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s R.","family":"Mu\u00f1oz-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron H.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114564_bb0005","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/db16-0946","article-title":"In vivo enrichment of diabetogenic T cells","volume":"66","author":"Thelin","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2025.114564_bb0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acsabm.0c01048","article-title":"Brain homogenate decoys for antigen-specific cell amplification","volume":"4","author":"Griffin","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2025.114564_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00281-002-0109-8","article-title":"Autoreactive T cells in endocrine\/organ-specific autoimmunity: why has progress been so slow?","volume":"24","author":"Roep","year":"2002","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114564_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nbt.4047","article-title":"Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells","volume":"36","author":"Cheung","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nri1245","article-title":"T-cell-antigen recognition and the immunological synapse","volume":"3","author":"Huppa","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0035","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3324\/haematol.12521","article-title":"The effect of artificial antigen-presenting cells with preclustered anti-CD28\/-CD3\/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells","volume":"93","author":"Zappasodi","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jconrel.2025.114564_bb0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nnano.2014.154","article-title":"A carbon nanotube\u2013polymer composite for T-cell therapy","volume":"9","author":"Fadel","year":"2014","journal-title":"Nature Nanotech"},{"key":"10.1016\/j.jconrel.2025.114564_bb0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1479-5876-8-104","article-title":"Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation","volume":"8","author":"Li","year":"2010","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114564_bb0050","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1038\/mtm.2014.1","article-title":"Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors","volume":"1","author":"Jin","year":"2014","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"key":"10.1016\/j.jconrel.2025.114564_bb0055","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1039\/D3BM00629H","article-title":"The foreign body response: emerging cell types and considerations for targeted therapeutics","volume":"11","author":"Yang","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114564_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","article-title":"Foreign body reaction to biomaterials","volume":"20","author":"Anderson","year":"2008","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0065","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jbm.a.35958","article-title":"The pathology of the foreign body reaction against biomaterials","volume":"105","author":"Klopfleisch","year":"2017","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2025.114564_bb0070","article-title":"Don\u2019t judge an implant by its cover: how the foreign body response and fibrotic capsule might be harnessed for good","author":"Dickenson","year":"2025","journal-title":"Npj Biomedical Innovations In Press"},{"key":"10.1016\/j.jconrel.2025.114564_bb0075","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1038\/s41467-020-17629-z","article-title":"Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis","volume":"11","author":"Morris","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114564_bb0080","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1158\/0008-5472.CAN-15-2106","article-title":"Enhanced survival with implantable scaffolds that capture metastatic breast Cancer cells in vivo","volume":"76","author":"Rao","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114564_bb0085","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409852122","article-title":"Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis","volume":"122","author":"Rad","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114564_bb0090","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1016\/j.biomaterials.2011.02.030","article-title":"Evolving the use of peptides as components of biomaterials","volume":"32","author":"Collier","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114564_bb0095","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/pharmaceutics16111468","article-title":"Peptide-based biomaterials for combatting infections and improving drug delivery","volume":"16","author":"Lombardi","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114564_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202200342","article-title":"Fabrication and bioactivity of peptide-conjugated biomaterial tissue engineering constructs","volume":"44","author":"Nun","year":"2023","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2025.114564_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.jconrel.2025.114564_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119440","article-title":"Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease","volume":"222","author":"Griffin","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114564_bb0115","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.ymthe.2017.04.015","article-title":"Controlled delivery of single or multiple antigens in tolerogenic nanoparticles using peptide-polymer bioconjugates","volume":"25","author":"Pearson","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114564_bb0120","article-title":"Bioactive fibrous scaffolds with programmable release of polypeptides regulate inflammation and extracellular matrix remodeling, regenerative","volume":"10","author":"Xiang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114564_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047585","article-title":"Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323\u2013339","volume":"7","author":"Roy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.114564_bb0130","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4049\/jimmunol.130.3.1033","article-title":"Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies","volume":"130","author":"White","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0135","series-title":"Janeway\u2019s Immunobiology, 9th Edition, GS, Garland Science","author":"Murphy","year":"2017"},{"key":"10.1016\/j.jconrel.2025.114564_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","article-title":"Defective TCR expression in transgenic mice constructed using cDNA-based \u03b1- and \u03b2-chain genes under the control of heterologous regulatory elements","volume":"76","author":"Barnden","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0145","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1210\/en.2009-0881","article-title":"Transgenic mice expressing green fluorescent protein under the control of the corticotropin-releasing hormone promoter","volume":"150","author":"Alon","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2025.114564_bb0150","series-title":"Methods in Enzymology","first-page":"239","article-title":"CFSE dilution to study human T and NK cell proliferation in vitro","author":"Terr\u00e9n","year":"2020"},{"key":"10.1016\/j.jconrel.2025.114564_bb0155","first-page":"2259","article-title":"The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation","author":"Quah","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jconrel.2025.114564_bb0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2014a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114564_bb0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/abio.1996.9920","article-title":"3-(4-Carboxybenzoyl)quinoline-2-carboxaldehyde, a reagent with broad dynamic range for the assay of proteins and lipoproteins in solution","volume":"244","author":"You","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2025.114564_bb0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2144\/000114190","article-title":"Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds","volume":"57","author":"Yap","year":"2014","journal-title":"BioTechniques"},{"key":"10.1016\/j.jconrel.2025.114564_bb0175","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1271\/bbb.120349","article-title":"Two distinct epitopes on the ovalbumin 323-339 peptide differentiating CD4+ T cells into the Th2 or Th1 phenotype","volume":"76","author":"Nakajima-Adachi","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.jconrel.2025.114564_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/intimm\/8.1.123","article-title":"TCR repertoire to proteolipid protein (PLP) in multiple sclerosis (MS): homologies between PLP-specific T cells and MS-associated T cells in TCR junctional sequences","volume":"8","author":"Kondo","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0185","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1074-7613(03)00296-6","article-title":"The IL-12 family of heterodimeric cytokines","volume":"19","author":"Trinchieri","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114564_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112897","article-title":"Simulating CD8 T cell exhaustion: A comprehensive approach","volume":"28","author":"Manrique-Rinc\u00f3n","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2025.114564_bb0195","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41563-018-0147-9","article-title":"Biomaterial-assisted targeted modulation of immune cells in cancer treatment","volume":"17","author":"Wang","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2025.114564_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120584","article-title":"Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy","volume":"268","author":"Isser","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114564_bb0205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2018.10.008","article-title":"Biomaterials for vaccine-based cancer immunotherapy","volume":"292","author":"Zhang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114564_bb0210","doi-asserted-by":"crossref","first-page":"eaav6313","DOI":"10.1126\/sciadv.aav6313","article-title":"Treating ischemia via recruitment of antigen-specific T cells","volume":"5","author":"Kwee","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114564_bb0215","doi-asserted-by":"crossref","first-page":"8ra19","DOI":"10.1126\/scitranslmed.3000359","article-title":"In situ regulation of DC subsets and T cells mediates tumor regression in mice","volume":"1","author":"Ali","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114564_bb0220","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1039\/D1BM00859E","article-title":"Spatial organization of biochemical cues in 3D-printed scaffolds to guide osteochondral tissue engineering","volume":"9","author":"Camacho","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114564_bb0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jconrel.2022.06.008","article-title":"CCL21 and beta-cell antigen releasing hydrogels as tolerance-inducing therapy in type I diabetes","volume":"348","author":"Zisi Tegou","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114564_bb0230","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ces.2014.08.046","article-title":"Controlled drug release from pharmaceutical nanocarriers","volume":"125","author":"Lee","year":"2015","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.jconrel.2025.114564_bb0235","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2025.114564_bb0240","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejpb.2023.05.019","article-title":"The processes behind drug loading and release in porous drug delivery systems","volume":"189","author":"Farzan","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114564_bb0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425241003602259","article-title":"Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems","volume":"7","author":"Fu","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114564_bb0250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0142-9612(95)93258-F","article-title":"Hydrolytic degradation of devices based on poly(dl-lactic acid) size-dependence","volume":"16","author":"Grizzi","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114564_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114322","article-title":"Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery","volume":"186","author":"Klepach","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114564_bb0260","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s13346-023-01424-6","article-title":"Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release","volume":"14","author":"Liang","year":"2024","journal-title":"Drug Deliv. and Transl. Res."},{"key":"10.1016\/j.jconrel.2025.114564_bb0265","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biomaterials.2018.11.015","article-title":"Localized immune tolerance from FasL-functionalized PLG scaffolds","volume":"192","author":"Skoumal","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114564_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1097871","article-title":"Immunogenic self-peptides - the great unknowns in autoimmunity: identifying T-cell epitopes driving the autoimmune response in autoimmune diseases","volume":"13","author":"Prinz","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0275","first-page":"109","article-title":"A SIINFEKL-based system to measure MHC class I antigen presentation efficiency and kinetics","volume":"2019","author":"Dersh","year":"1988","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0280","article-title":"In vivo stimulation of therapeutic antigen-specific T cells in an artificial lymph node matrix","volume":"36","author":"Livingston","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114564_bb0285","article-title":"Engineering an artificial T-cell stimulating matrix for immunotherapy","volume":"31","author":"Hickey","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114564_bb0290","first-page":"241","article-title":"Dendritic cell-mimicking scaffolds for ex vivo T cell expansion","volume":"21","author":"Kim","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.114564_bb0295","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41587-024-02505-8","article-title":"Targeting peptide antigens using a multiallelic MHC I-binding system","volume":"43","author":"Du","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/cells13010013","article-title":"Differential activation of splenic cDC1 and cDC2 cell subsets following poxvirus infection of BALB\/c and C57BL\/6 mice","volume":"13","author":"Szulc-D\u0105browska","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.114564_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1501s77","article-title":"Experimental autoimmune encephalomyelitis in the mouse","volume":"77","author":"Miller","year":"2007","journal-title":"CP in Immunology"},{"key":"10.1016\/j.jconrel.2025.114564_bb0310","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.autrev.2005.03.005","article-title":"The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE)","volume":"4","author":"Ziemssen","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2025.114564_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2025.114564_bb0320","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2011.01016.x","article-title":"Immune tolerance in multiple sclerosis","volume":"241","author":"Goverman","year":"2011","journal-title":"Immunol. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:24:20Z","timestamp":1781702660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":64,"alternative-id":["S0168365925011782"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114564","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigen-conjugated scaffolds enable sustained delivery of antigen and enrichment of antigen-specific T-cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114564"}}